HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY
As of 18 November 2026, for the company name HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY as recorded, the chemical-drug catalogue lists 32 active records with this name as holder; 41 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
70 acceptance records as first applicant, grouped into 21 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Flunarizine Hydrochloride Capsules 2 records · Latest accepted 2026/11/04
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601996 | Supplement | 2026/11/04 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY; Ha Yao Group San Jing Er Tong Da Pharmaceutical Factory (Co., Ltd.) romanized | CDE ↗ |
| CYHB2150567 | Supplement | 2021/05/06 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
Aztreonam For Injection 3 records · Latest accepted 2026/08/28
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2650179 | Supplement | 2026/08/28 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY; Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2650178 | Supplement | 2026/08/28 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY; Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2650177 | Supplement | 2026/08/28 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY; Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | CDE ↗ |
Cefoxitin Sodium for Injection 2 records · Latest accepted 2026/08/17
Supplement · 2
Ampicillin Sodium and Sulbactam Sodium for Injection 4 records · Latest accepted 2026/04/25
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2650101 | Supplement | 2026/04/25 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2650100 | Supplement | 2026/04/25 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2650099 | Supplement | 2026/04/25 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2650098 | Supplement | 2026/04/25 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
Cefuroxime Sodium for Injection 3 records · Latest accepted 2026/04/21
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2650096 | Supplement | 2026/04/21 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2650095 | Supplement | 2026/04/21 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2650094 | Supplement | 2026/04/21 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
Cefcapene Pivoxil Hydrochloride Granules 1 records · Latest accepted 2026/03/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600653 | Generic | 2026/03/13 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY; Kinhoo Pharmaceutical Co., Ltd. | CDE ↗ |
Ceftriaxone Sodium for Injection 11 records · Latest accepted 2026/02/27
Supplement · 11
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600403 | Supplement | 2026/02/27 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2502129 | Supplement | 2025/10/18 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2502128 | Supplement | 2025/10/18 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2401143 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2401142 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2401141 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2401140 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2401139 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2401138 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2350213 | Supplement | 2023/02/24 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2350212 | Supplement | 2023/02/24 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
Piperacillin Sodium for Injection 2 records · Latest accepted 2026/01/28
Supplement · 2
注射用头孢唑肟钠 · No verified English name 4 records · Latest accepted 2025/08/27
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550309 | Supplement | 2025/08/27 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2550308 | Supplement | 2025/08/27 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2550307 | Supplement | 2025/08/27 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2550306 | Supplement | 2025/08/27 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
Cefmetazole Sodium for Injection 6 records · Latest accepted 2025/01/11
Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500073 | Supplement | 2025/01/11 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2500072 | Supplement | 2025/01/11 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2500071 | Supplement | 2025/01/11 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2150831 | Supplement | 2021/08/27 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2150830 | Supplement | 2021/08/27 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2150829 | Supplement | 2021/08/27 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
Cefotaxime Sodium For Injection 4 records · Latest accepted 2025/01/04
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550019 | Supplement | 2025/01/04 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2550018 | Supplement | 2025/01/04 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2400921 | Supplement | 2024/06/28 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2400920 | Supplement | 2024/06/28 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
诺氟沙星胶囊 · No verified English name 1 records · Latest accepted 2024/12/14
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450612 | Supplement | 2024/12/14 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY; Ha Yao Group Pharmaceutical Liu Factory romanized | CDE ↗ |
Ceftazidime And Avibactam Sodium For Injection 1 records · Latest accepted 2024/09/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403239 | Generic | 2024/09/26 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
Cefoperazone Sodium and Sulbactam Sodium for Injection 9 records · Latest accepted 2024/09/07
Supplement · 9
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450470 | Supplement | 2024/09/07 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2450469 | Supplement | 2024/09/07 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2450468 | Supplement | 2024/09/07 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2450467 | Supplement | 2024/09/07 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2401134 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2401133 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2401132 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2401130 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2401129 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
Norfloxacin Tablets 2 records · Latest accepted 2024/07/04
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400988 | Supplement | 2024/07/04 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY; Ha Yao Group Pharmaceutical Liu Factory romanized | CDE ↗ |
| CYHB2150083 | Supplement | 2021/01/29 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
Cefazolin Sodium for Injection 4 records · Latest accepted 2024/07/03
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400961 | Supplement | 2024/07/03 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2400960 | Supplement | 2024/07/03 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2400036 | Supplement | 2024/01/04 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2400035 | Supplement | 2024/01/04 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
Ceftazidime for Injection 3 records · Latest accepted 2024/06/28
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400919 | Supplement | 2024/06/28 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2450162 | Supplement | 2024/03/01 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2450161 | Supplement | 2024/03/01 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
Penicillin G Sodium For Injection 4 records · Latest accepted 2023/05/04
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350406 | Supplement | 2023/05/04 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2350405 | Supplement | 2023/05/04 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2350404 | Supplement | 2023/05/04 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| CYHB2350403 | Supplement | 2023/05/04 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
头孢拉定胶囊 · No verified English name 1 records · Latest accepted 2023/04/26
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300896 | Supplement | 2023/04/26 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY; Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | CDE ↗ |
Cefalexin Capsules 1 records · Latest accepted 2023/02/22
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300366 | Supplement | 2023/02/22 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY; Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | CDE ↗ |
Cefotiam Hydrochloride For Injection 2 records · Latest accepted 2021/07/02
Supplement · 2
Changes in the last 90 days
8 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 4 applicationsNo longer listed under review: 2 applicationsSupplement delivery: 2 applications
- 2026/11/07No longer listed under review
注射用头孢唑肟钠 · No verified English name
CYHB2550309
Fact date: 2026/11/07 · Date added to this site: 2026/11/07
Accepted: 2025/08/27
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 11
NMPA · Table row 11 ↗ View source ↗ - 2026/11/07No longer listed under review
注射用头孢唑肟钠 · No verified English name
CYHB2550306
Fact date: 2026/11/07 · Date added to this site: 2026/11/07
Accepted: 2025/08/27
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 10
NMPA · Table row 10 ↗ View source ↗ - 2026/11/05Supplement delivery
注射用头孢唑肟钠 · No verified English name
CYHB2550309
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Date added to this site: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 11 ↗ - 2026/11/05Supplement delivery
注射用头孢唑肟钠 · No verified English name
CYHB2550306
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Date added to this site: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 10 ↗ - 2026/11/04Accepted
Flunarizine Hydrochloride Capsules
CYHB2601996
Fact date: 2026/11/04 · Date added to this site: 2026/11/05
View source ↗ - 2026/08/28Accepted
Aztreonam For Injection
CYHB2650179
Fact date: 2026/08/28 · Date added to this site: 2026/10/22
View source ↗ - 2026/08/28Accepted
Aztreonam For Injection
CYHB2650178
Fact date: 2026/08/28 · Date added to this site: 2026/10/22
View source ↗ - 2026/08/28Accepted
Aztreonam For Injection
CYHB2650177
Fact date: 2026/08/28 · Date added to this site: 2026/10/22
View source ↗
Under review
32 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Flunarizine Hydrochloride Capsules | CYHB2601996 | Supplement | 2026/11/04 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY; Ha Yao Group San Jing Er Tong Da Pharmaceutical Factory (Co., Ltd.) romanized | CDE ↗ |
| Aztreonam For Injection | CYHB2650179 | Supplement | 2026/08/28 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY; Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | CDE ↗ |
| Aztreonam For Injection | CYHB2650178 | Supplement | 2026/08/28 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY; Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | CDE ↗ |
| Aztreonam For Injection | CYHB2650177 | Supplement | 2026/08/28 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY; Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | CDE ↗ |
| Cefoxitin Sodium for Injection | CYHB2601555 | Supplement | 2026/08/17 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Ampicillin Sodium and Sulbactam Sodium for Injection | CYHB2650101 | Supplement | 2026/04/25 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Ampicillin Sodium and Sulbactam Sodium for Injection | CYHB2650100 | Supplement | 2026/04/25 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Ampicillin Sodium and Sulbactam Sodium for Injection | CYHB2650099 | Supplement | 2026/04/25 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Ampicillin Sodium and Sulbactam Sodium for Injection | CYHB2650098 | Supplement | 2026/04/25 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Cefuroxime Sodium for Injection | CYHB2650096 | Supplement | 2026/04/21 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Cefuroxime Sodium for Injection | CYHB2650095 | Supplement | 2026/04/21 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Cefuroxime Sodium for Injection | CYHB2650094 | Supplement | 2026/04/21 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Cefcapene Pivoxil Hydrochloride Granules | CYHS2600653 | Generic | 2026/03/13 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY; Kinhoo Pharmaceutical Co., Ltd. | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2600403 | Supplement | 2026/02/27 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Piperacillin Sodium for Injection | CYHB2650028 | Supplement | 2026/01/28 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Piperacillin Sodium for Injection | CYHB2650027 | Supplement | 2026/01/28 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2401143 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2401142 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2401141 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2401140 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2401139 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2401138 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | CYHB2401134 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | CYHB2401133 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | CYHB2401132 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | CYHB2401130 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | CYHB2401129 | Supplement | 2024/07/30 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Cefazolin Sodium for Injection | CYHB2400961 | Supplement | 2024/07/03 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Cefazolin Sodium for Injection | CYHB2400960 | Supplement | 2024/07/03 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Cefotaxime Sodium For Injection | CYHB2400921 | Supplement | 2024/06/28 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Cefotaxime Sodium For Injection | CYHB2400920 | Supplement | 2024/06/28 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| Ceftazidime for Injection | CYHB2400919 | Supplement | 2024/06/28 | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
Catalogue holder records
32 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Ceftazidime And Avibactam Sodium For Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H20264794 | 2026/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefotaxime Sodium For Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H23020947 | 2026/02/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotaxime Sodium For Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H23020948 | 2026/02/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H20033424 | 2026/01/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H20063768 | 2026/01/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H20063769 | 2026/01/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H19980085 | 2026/01/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 诺氟沙星胶囊 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Ha Yao Group Pharmaceutical Liu Factory romanized | 国药准字H23020934 | 2025/06/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftazidime for Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H23021723 | 2025/04/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoxitin Sodium for Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H20059326 | 2025/01/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Penicillin G Sodium For Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H23021439 | 2024/08/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Penicillin G Sodium For Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H23021441 | 2024/08/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Penicillin G Sodium For Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H23020930 | 2024/08/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Penicillin G Sodium For Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H20023737 | 2024/08/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H23021721 | 2024/01/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H23021720 | 2024/01/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefmetazole Sodium for Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H20070239 | 2023/01/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotiam Hydrochloride For Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H20041468 | 2023/01/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotiam Hydrochloride For Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H20041469 | 2023/01/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Flunarizine Hydrochloride Capsules | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H19993926 | 2022/10/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Norfloxacin Tablets | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H23023318 | 2022/07/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 头孢拉定胶囊 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H23020938 | 2022/04/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ampicillin Sodium For Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H20023720 | 2022/01/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ampicillin Sodium For Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H23020926 | 2022/01/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ampicillin Sodium For Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H23020927 | 2022/01/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefazolin Sodium for Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H23020945 | 2021/12/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefazolin Sodium for Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H23020946 | 2021/12/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Azithromycin Tablets | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H20103507 | 2021/11/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefalexin Capsules | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H23020936 | 2020/12/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftazidime for Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H20033020 | 2025/04/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefmetazole Sodium for Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H20070240 | 2023/01/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefmetazole Sodium for Injection | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | 国药准字H20237011 | 2023/01/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
41 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 阿莫西林 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190009694 | A | 2025/07/19 | CDE ↗ |
| 头孢西丁钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190008073 | A | 2024/08/16 | CDE ↗ |
| 头孢他啶 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190008072 | A | 2025/07/19 | CDE ↗ |
| 头孢拉定/L-精氨酸 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190006885 | A | 2024/03/09 | CDE ↗ |
| 头孢美唑钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190006731 | A | 2024/06/06 | CDE ↗ |
| 头孢他啶(含碳酸钠) · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190006574 | A | 2024/03/09 | CDE ↗ |
| 盐酸林可霉素 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005813 | A | 2025/09/18 | CDE ↗ |
| 头孢孟多酯钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005722 | A | 2024/08/16 | CDE ↗ |
| 盐酸头孢他美酯 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005219 | A | 2024/07/05 | CDE ↗ |
| 头孢唑肟钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005210 | A | 2025/07/19 | CDE ↗ |
| 头孢噻吩钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005208 | A | 2024/08/16 | CDE ↗ |
| 青霉素钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005205 | A | 2025/06/26 | CDE ↗ |
| 头孢氨苄 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005204 | A | 2025/07/19 | CDE ↗ |
| 头孢拉定 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005203 | A | 2025/09/19 | CDE ↗ |
| 头孢唑林钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005202 | A | 2025/07/19 | CDE ↗ |
| 头孢曲松钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005196 | A | 2025/07/19 | CDE ↗ |
| 盐酸头孢替安 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005195 | A | 2025/07/19 | CDE ↗ |
| 阿莫西林钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005194 | A | 2025/07/19 | CDE ↗ |
| 头孢呋辛钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005190 | A | 2024/08/16 | CDE ↗ |
| 头孢替唑钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005188 | A | 2025/07/19 | CDE ↗ |
| 舒巴坦钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005185 | A | 2025/07/19 | CDE ↗ |
| 葡萄糖酸锌 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005176 | A | 2024/08/16 | CDE ↗ |
| 头孢哌酮钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005175 | A | 2024/08/16 | CDE ↗ |
| 盐酸头孢吡肟 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005174 | A | 2024/08/16 | CDE ↗ |
| 葡萄糖酸钙 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005172 | A | 2024/07/05 | CDE ↗ |
| 头孢噻肟钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005169 | A | 2025/07/19 | CDE ↗ |
| 氨苄西林钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005168 | A | 2025/07/19 | CDE ↗ |
| 托西酸舒他西林 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005163 | A | 2024/07/05 | CDE ↗ |
| 盐酸伊托必利 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190005162 | A | 2024/07/17 | CDE ↗ |
| 氨曲南 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190001296 | A | 2024/08/16 | CDE ↗ |
| 头孢米诺钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190001240 | A | 2024/09/12 | CDE ↗ |
| 碳酸氢钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20190001202 | A | 2024/08/16 | CDE ↗ |
| 阿莫西林 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20170001911 | I | — | CDE ↗ |
| 米诺膦酸 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20170001203 | I | — | CDE ↗ |
| 卡培他滨 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20170001159 | I | — | CDE ↗ |
| 来曲唑 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20170001065 | I | — | CDE ↗ |
| 达沙替尼 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20170001017 | I | — | CDE ↗ |
| 阿那曲唑 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20170000947 | I | — | CDE ↗ |
| 盐酸头孢甲肟 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20170000860 | I | — | CDE ↗ |
| 恩替卡韦 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20170000681 | I | — | CDE ↗ |
| 无水碳酸钠 · No verified English name | HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | Y20170000246 | A | 2024/11/21 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
2 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 脉安颗粒 · No verified English name | CYZB2200672 | Supplement | 2022/06/24 | Ha Yao Group Shi Yi Tang Pharmaceutical Factory romanized; HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
| 复方胆通胶囊 · No verified English name | CYZB2200598 | Supplement | 2022/06/09 | Ha Yao Group Shi Yi Tang Pharmaceutical Factory romanized; HARBIN PHARMACEUTICAL GROUP CO., LTD. GENERAL PHARM. FACTORY | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.